The secret of a foreign company recording over KRW 70 billion only with 4 products is ‘specialization’
There is a foreign pharmaceutical company recording KRW 70 billion sales in the domestic market only with 4 product approvals.
The leading role of the drama is ‘Gilead Sciences Korea’ acquiring an approval for the pharmaceutical importing business since 2 February 2013.
Gilead Sciences Korea’s ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
